Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to... see more

TSXV:BTI - Post Discussion

Bioasis Technologies Inc. > Not bad, Finallytherock...
View:
Post by JDavenport on Feb 17, 2022 10:51am

Not bad, Finallytherock...

Yours is one of the best meltdowns I've seen in years.

I think I'll just sit back and admire it. 

jd
Comment by Finallytherock on Feb 17, 2022 10:53am
Meltdowns? LOL, Sadly, I am just pointing out the truth. Although the truth could look scary and much like a meltdown, right? Anything i say incorrect? How much does the company owe you?
Comment by Finallytherock on Feb 17, 2022 10:54am
My apologies, are you referring to the meltdown in the stock price over the years? LOL
Comment by JDavenport on Feb 17, 2022 11:23am
Yo, Finallytherock, I think you should send your message to Chiesi, Aposense, Oxyrane and Daiichi Sankyo. Gather yourself up for a moment, and if you can achieve sufficient lucidity, send the message that it's over, that they shouldn't be wasting their money. I think it's only fair you share that with them. jd
Comment by Finallytherock on Feb 17, 2022 11:31am
What has come out of any of these partnerships? Nothing. It's been almost 2 years with Chiesi and no updates? Come on. That's not good...you know that. And bioaf mentioning assessing strategic alternatives is never a good sign. Nothing from the Ceo in quite a while. Again, your ego is getting in the way of clear thinking. You can't fathom having spent years of your time here only to ...more  
Comment by chrispi on Feb 17, 2022 11:55am
Hey Finallytherock, see this post written for you Watch and learn grasshopper, watch and learn. (need a scoreboard reminder again?)
Comment by narmac on Feb 17, 2022 12:10pm
,,,just a riminder that we also have a support system to give direction as we push forward,,,and non of the members on these boards would be considerd slouches,,,,,MBAs, CPAs, MDs and PhDs make up the cross sections. Our Scientific board has 4 PhDs onboard not counting Mei Mei, Sprouse and DrDR.,,,thats impressive imo!!! 1) BoD 2) Medical Advisory Board 3) Science Advisory Board
Comment by narmac on Feb 17, 2022 12:12pm
,,,,BTI,,,,,,TO THE MOOOOOOOOOOOOON,,,,,,,,CAN YOU SAY IT??,,,,,,,,WOOOOOHOOOOOO!!!..I'M RIGHT TINGLY ALL OVER!!!!!!!
Comment by ronrydell on Feb 17, 2022 4:23pm
Debra should send all or part of that money to JD and regain her partial cred!
Comment by Finallytherock on Feb 17, 2022 12:11pm
Nice one. It's cute watching you try 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities